According to a new report from Intel Market Research, the global Medical Polymers market was valued at USD 16.66 billion in 2024 and is projected to reach USD 20.88 billion by 2032, growing at a CAGR of 3.4% during the forecast period (2025–2032). This growth is propelled by the increasing global prevalence of chronic diseases, heightened awareness about advanced medical devices, and significant advancements in polymer science.
Read MoreAccording to a new report from Intel Market Research , the global amorphous 3D wound core transformer market was valued at USD 334 million in 2024 and is projected to reach USD 471 million by 2032 , growing at a steady CAGR of 5.4% during the forecast period (2025–2032). This growth is driven by increasing global energy efficiency mandates, smart grid modernization initiatives, and rising electricity demand in emerging economies.
Read MoreAccording to a new report from Intel Market Research, the global Gamma-Nonanoic Lactone market was valued at USD 27.5 million in 2024 and is projected to reach USD 32.5 million by 2032, growing at a CAGR of 2.5% during the forecast period (2025–2032). This steady growth reflects the compound's specialized applications in flavor and fragrance industries, coupled with expanding demand for tropical and gourmand scent profiles.
Read MoreAccording to a new report from Intel Market Research, the global Gamma-Nonanoic Lactone market was valued at USD 27.5 million in 2024 and is projected to reach USD 32.5 million by 2032, growing at a CAGR of 2.5% during the forecast period (2025–2032). This steady growth reflects the compound's specialized applications in flavor and fragrance industries, coupled with expanding demand for tropical and gourmand scent profiles.
Read MoreAccording to a new report from Intel Market Research, the global Tissue Engineering market was valued at USD 34.56 billion in 2024 and is projected to reach USD 120.57 billion by 2032, growing at a strong CAGR of 20.0% during the forecast period (2025–2032). This growth is propelled by the increasing global prevalence of chronic and degenerative diseases, heightened healthcare focus on regenerative treatments, and continuous advancements in biomaterial and bioprinting technologies.
Read More